ArticlePloS one2020

Preclinical characterization of CPL302-253, a selective inhibitor of PI3Kδ, as the candidate for the inhalatory treatment and prevention of Asthma.

Paweł Gunerka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.